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Abstract
Background: Vitamin D reportedly influences vascular function, 
which is worse in African Americans (AAs) relative to European 
Americans (EAs). It is not clear if ethnic differences in 25(OH)
D mediate differences in vascular function. This study examined 
the relationships of serum 25-hydroxyvitamin D (25(OH)D) with 
indicators of vascular function among healthy, young AA and EA 
adults.
Methods: This is a cross sectional study involving 23 AAs and 22 
EAs. The main outcomes were augmentation index (AIx75), central 
aortic pressure, pulse wave velocity (PWV), flow-mediated dilation 
(FMD), and seated and supine blood pressures.
Results: Results indicated that 25(OH)D was inversely associated 
with AIx75, supine systolic blood pressure (SBP), central aortic 
SBP and central aortic diastolic blood pressure (DBP), independent 
of age, sex, and percent body fat (standardized β= -0.29 to -0.43, 
P < 0.05 for all).  AAs had greater AIx75 (P = 0.04) and PWV (P = 
0.07) and lower FMD (P = 0.02) compared to EA after adjusting for 
age and percent body fat; further adjustment for 25(OH)D reduced 
the ethnic differences (P = 0.44, 0.53, and 0.20, respectively).
Conclusions: The 25(OH)D was associated with vascular function 
in healthy adults, and lower 25(OH)D among AAs may contribute 
to their greater arterial stiffness and reduced endothelial function 
(Clinical trials.gov NCT01041365, NCT01041547).
Keywords:  Vitamin  D;  Hypertension;  Blood  pressure;  African 
Americans; Augmentation index; Pulse wave velocity; Flow medi-
ated dilation; Vascular function
Introduction
Increasing evidence suggests a role for vitamin D in the 
maintenance of cardiovascular health.  Several cross-sec-
tional and longitudinal cohort studies have reported rela-
tionships between vitamin D deficiencies and the conven-
tional  cardiovascular  risk  factor,  hypertension,  although 
vitamin D intervention trials to reduce blood pressure have 
yielded inconclusive results, as recently reviewed [1]. Few-
er studies, however, have investigated the role of vitamin D 
on non-traditional independent predictors of cardiovascular 
risk such as arterial stiffness as determined by pulse wave 
velocity (PWV) and endothelial dysfunction measured by 
flow  mediated  dilatation  (FMD),  particularly  in  healthy 
populations [2-7]. Given that endothelial dysfunction and 
arterial stiffness are considered sub-clinical markers of vas-
cular damage and have been hypothesized to precede the 
manifestation of hypertension [8, 9], further study inves-
tigating the relationships of serum 25-hydroxy vitamin D 
(25(OH)D) with PWV and FMD in healthy, young adults 
is warranted.  
African Americans (AAs) have a greater prevalence of 
hypertension and have been shown to have greater arterial 
stiffness and endothelial dysfunction compared to European 
Americans (EAs) [10-12]. It is plausible that lower 25(OH)
D among AAs relative to EAs [13] may partially account for 
their relatively poorer vascular health. Indeed, studies have 
reported a reduction in the ethnic difference in vascular mor-
bidity and mortality after accounting for circulating 25(OH)
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D [14-17]. Few studies have investigated this hypothesis us-
ing intermediate endpoints of vascular disease, such as FMD 
or PWV [7]. Furthermore, it is not known if relationships 
between 25(OH)D and these aforesaid vascular outcomes 
differ by ethnicity.      
The purpose of this study was to investigate the relation-
ships of 25(OH)D with indices of vascular function, namely 
FMD, PWV, and augmentation index (AIx) in healthy AA 
and EA men and women. We hypothesized that circulating 
25(OH)D would be inversely associated with PWV, inverse-
ly associated with AIx, and positively associated with FMD. 
We further hypothesized that lower 25(OH)D among AAs 
contributes to the ethnic differences in vascular function.
Methods
Participants
Participants were 23 AA and 22 EA adults ages 18 - 50 re-
cruited through flyers and newspaper advertisements. Data 
were collected between February and May 2010. Ethnicity/
race  was  self-defined.  Exclusion  criteria  included  self-re-
ported history of diabetes, hypertension, or any other condi-
tion known to influence insulin sensitivity or vascular func-
tion, such as polycystic ovary syndrome; anti-hypertensive, 
glucose-controlling, or lipid-lowering medications; mono-
phasic oral contraceptive, hormonal intrauterine device, or 
injectable contraceptive use; current smoking status; lactose 
intolerance; or measured BMI > 32 kg/m2. Three women 
were self-classified as postmenopausal. Dietary supplemen-
tal use was not reported by any participants. All research 
was approved by the University of Alabama at Birmingham 
(UAB) Institutional Review Board for Human Use. Writ-
ten informed consent (parent consent and subject assent for 
those less than 19 yrs) was obtained before testing.    
Protocol
Testing  was  performed  over  2  separate  days  within  one 
week. Fasted blood samples, seated BP, body composition, 
and anthropometrics were obtained after a 12-hr fast. Radial 
PWA, carotid-femoral PWV, and FMD testing occurred on a 
separate morning after an 8-hr fast by a single physician who 
was blinded to participant vitamin D status.  
Vascular outcomes
Seated and supine blood pressure
Seated  blood  pressure  (BP)  was  measured  by  a  trained 
research  nurse  using  an  electronic  auscultatory  method 
(Dinamap Pro 200, GE Medical Systems, Milwaukee, WI). 
Two measurements were taken within 5 minutes of each oth-
er and averaged. A third measurement was taken if systolic 
BP (SBP) or Diastolic BP (DBP) differed by 5 mmHg or 
Variables All (n = 45) AA (n = 23) EA (n = 22) Pethnic group
a
Age (yr)      29.1 ± 6.8 31.0 ± 6.3 27.1 ± 6.9 0.06
Female gender (%) 80% 87% 73% 0.23
Height (cm) 167.1 ± 7.5 167.4 ± 6.9 166.7 ± 8.3 0.76
Weight (kg)   68.9 ± 13.7 72.6 ± 13.8 65.0 ± 12.8 0.06
BMI (kg/m2) 24.5 ± 4.0 25.8 ± 4.2 23.2 ± 3.2 0.02
Waist circumference (cm) 77.0 ± 10.4 78.9 ± 10.8 74.9 ± 9.8 0.20
Percent body fat (%) 30.8 ± 8.0 33.7 ± 8.3 27.7 ± 6.5 0.01
SES total score 41.9 ± 13.5 39.2 ± 12.5† 44.5 ± 14.2 0.20
Physical activity score 8.0 ± 1.4 7.9 ± 1.4b 8.2 ± 1.4c 0.57
Table 1. Descriptive Characteristics Among all Participants and by Ethnic Group
Abbreviations: AA, African American; EA, European American; BMI, body mass index. aAs measured by two-group 
t-test.  bn = 22, cn = 19, †n = 22
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more. Supine BP measurement before vascular function test-
ing was performed after participants rested for at least 5 min-
utes, using the auscultatory method, with the arm properly 
supported and using the correct cuff size. BP was measured 
in both arms, and the average of two readings in the arm with 
the higher blood pressure reading was used.  
Pulse wave analysis and pulse wave velocity
Radial PWA and carotid-femoral PWV were performed us-
ing the Sphygmocor applanation tonometry system (AtCor 
Medical, Sydney, Australia) and assessed as previously de-
scribed [18].  Participants were in the supine position. Brief-
ly, a central aortic pressure waveform was derived from a 
measured radial artery pressure waveform. AIx was calcu-
lated as the difference between the first and second systolic 
peaks of the ascending aortic waveform divided by the dif-
ference between central aortic SBP and central aortic DBP. 
AIx was standardized to a heart rate of 75 beats/min (AIx75). 
To determine PWV, ECG-gated pulse pressure waveforms 
were obtained sequentially over the right carotid artery and 
the right femoral artery. PWV was calculated as the transit 
distance between the measurement sites divided by the tran-
sit time computed as the time interval between the feet of the 
two pressure waves. 
Flow-mediated dilation
FMD  was  measured  non-invasively  via  high-resolution 
ultrasound with a 7.5 MHz linear-array probe (Philips HP 
Agilent Sonos 5500, Andover, MA) after a 30 min rest in the 
supine position in a quiet, air-conditioned room according 
to standard guidelines [19]. Briefly, ischemia and reactive 
hyperemia were induced by inflation of a BP cuff around the 
forearm to 50 mmHg above the subject’s supine SBP for 5 
min followed by rapid deflation. Images of the brachial ar-
Table 2. Serum 25(OH)D and Vascular Measures Among all Participants and by Ethnic Group
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AA, African American; EA, European American; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; AIx, augmentation index; AIx75, augmentation index standardized to a heart rate of 75 beats/min; 
PWV, pulse wave velocity; FMD, flow-mediated dilation. an = 23 AA, 22 CA unless otherwise specified. bAs measured by two-
group t-test. cTo convert to nmol/L, multiply by 2.946. dDefined as 25(OH)D ≤ 20 ng/mL. en = 22, fn = 21, gn = 18.
Variablesa All  AA EA Pethnic group
b
25(OH)D (ng/mL)c 21.9 ± 10.1 15.2 ± 5.1 28.8 ± 9.4 < 0.001
Vitamin D insufficiencyd (n, %) 23 (51%) 18 (82%) 4 (18%) < 0.001
Seated SBP (mmHg) 110 ± 13 109 ± 12 109 ± 14 0.96
Seated DBP (mmHg) 68 ± 8 70 ± 8 67 ± 7 0.26
Supine SBP (mmHg)  115 ± 11 116 ± 9e   113 ± 12 0.36
Supine DBP (mmHg)  72 ± 7 72 ± 6e  71 ± 9 0.48
Heart rate (beats/min) 64 ± 8 65 ± 8 62 ± 8 0.18
AIx (%)  10.9 ± 10.2 14.9 ± 9.1 6.6 ± 9.6f  0.005
AIx75 (%)   5.6 ± 10.7 10.2 ± 8.1 0.5 ± 11.1f   0.002
Aortic SBP (mmHg) 101 ± 9 103 ± 7 99 ± 10 0.08
Aortic DBP (mmHg) 72 ± 8 74 ± 6 71 ± 10 0.26
PWV (m/s)  6.6 ± 0.8 7.0 ± 0.8e   6.2 ± 0.7g   0.005
Baseline diameter (mm)  0.35 ± 0.05 0.35 ± 0.06e 0.34 ± 0.05f 0.60
FMD (%)   9.54 ± 2.44 8.61 ± 2.16e 10.52 ± 2.39f 0.009
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tery were recorded continuously for 1 min at baseline before 
cuff inflation and again for 30 sec prior to cuff deflation until 
2 min after cuff deflation. Arterial diameter measurements 
were obtained every 5 cardiac cycles at the end-diastolic 
cardiac phase for baseline, which was confirmed by the inci-
dent R wave on a synchronized electrocardiogram. For peak 
dilation, every cardiac cycle was measured during reactive 
hyperemia, and the 5 largest diameters were averaged. FMD 
was  defined  as  the  percentage  increase  in  diameter  from 
baseline to peak dilation.  
Serum analysis, body composition, and anthropometrics
Serum 25(OH)D was measured using liquid chromatogra-
phy mass spectrometry (Quest Diagnostics, San Juan Cap-
istrano, CA). Vitamin D status was classified as vitamin D 
insufficient if 25(OH)D concentration was less than or equal 
to 20 ng/mL. Percentage body fat (% fat) was measured with 
dual energy X-ray absorptiometry (iDXA, GE-LUNAR Ra-
diation Corp., Madison, WI) with participants lying in the 
supine position with their arms at their sides. Waist circum-
ference was measured around the narrowest portion of the 
torso with a flexible tape measure (Gulick II; County Tech-
nology, Inc., Gays Mills, WI).  
Questionnaires
SES was measured using the Hollingshead Four-Factor In-
dex of Social Status [20]. A higher score reflects greater SES 
(scores range from 8 to 66). Physical activity was measured 
with the validated Beacke Activity Questionnaire; a higher 
score indicates greater reported physical activity [21].  
Statistical analyses
Descriptive statistics (mean ± SD) were determined for all 
variables among all participants and by ethnic group. Values 
greater than 3 SD above or below the mean were removed 
as outliers.  Simple Pearson correlations were used to ex-
plore relationships of 25(OH)D with vascular outcomes and 
age. Vascular outcomes found to be significant or approach-
ing  significance  were  used  in  subsequent  multiple  linear 
regression (MLR) analyses to investigate the relationships 
between 25(OH)D and vascular outcomes independent of 
ethnic group, age, and sex. In order to be considered during 
initial model building, 25(OH)D had to have a P-value of 
0.20 or less.  Percent body fat and waist circumference were 
further examined as potential confounders in MLR analy-
ses. Preliminary analyses indicated potential collinearity be-
tween ethnic group and 25(OH)D; thus, relationships were 
also analyzed within each ethnic group. Differences between 
the ethnic groups were determined using t-tests, chi-squared 
tests, or analysis of covariance (sequentially adjusting for 
age, percent body fat, and 25(OH)D concentrations). The 
distributions of studentized residuals for all MLR models 
were examined, and residuals greater than 3 SD above or be-
low the mean were considered outliers and subsequently re-
moved from analyses. All tests were two-sided and assumed 
a 5% significance level. Analyses were performed using SAS 
software (version 9.1; SAS Institute, Cary, NC).
 
Results
Descriptive characteristics of all participants combined and 
within each ethnic group are shown in Table 1. Participants 
were generally relatively young (mean age 29.1 ± 6.8 yr) and 
of normal weight (mean BMI 24.5 ± 4.0 kg/m2). A majority 
of the participants were female (80%). AA tended to be older 
(P = 0.06), had greater BMI (P = 0.049) and greater percent 
body fat (P = 0.01) than EA. AA had significantly lower 
25(OH)D (P < 0.001), greater AIx (P = 0.005), greater AIx75 
(P = 0.002), greater PWV (P = 0.005), and lower FMD (P < 
0.05) compared to EA (Table 2). Reported physical activity 
or SES did not differ between ethnic groups (P = 0.57 and 
0.20,  respectively). Twenty-three  participants  (51%)  were 
classified as vitamin D insufficient; of these, 82% were AA.
Simple Pearson correlation analyses indicated a signifi-
cant relationship or a trend towards significance of 25(OH)
Table 3. Pearson Correlations of 25(OH)
D With Vascular Outcomes (r (P-value))
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; 
AIx75, augmentation index standardized to a 
heart rate of 75 beats/min; PWV, pulse wave 
velocity;  FMD,  flow-mediated  dilation;  SBP, 
systolic  blood  pressure;  DBP,  diastolic  blood 
pressure.
25(OH)D
AIx75 - 0.35 (0.02)
PWV - 0.39 (0.009)
FMD 0.37 (0.01)
Seated SBP - 0.14 (0.37)
Seated DBP - 0.11 (0.48)
Supine SBP - 0.29 (0.06)
Supine DBP - 0.11 (0.46)
Aortic SBP - 0.32 (0.03)
Aortic DBP - 0.27 (0.08)
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D with several vascular outcomes, but not seated BP or su-
pine DBP (Table 3). In exploratory MLR analyses for AIx75, 
supine SBP, and aortic BP as the dependent variables with 
age,  sex,  ethnic  group,  and  25(OH)D  as  the  independent 
variables, ethnic group was not a significant predictor in the 
models (P = 0.43 to 0.87) whereas 25(OH)D was either sta-
tistically significant or approached significance (P = 0.04 to 
0.098). Removal of ethnic group from the models resulted 
in a significant contribution of 25(OH)D (P < 0.05 for all). 
As depicted in Figure 1, the relationship of 25(OH)D with 
AIx75, supine SBP, aortic SBP, and aortic DBP remained 
statistically significant after incorporating percent body fat 
to the models. The addition of SES or physical activity to the 
models did not alter the results (P = 0.009 - 0.04) with the ex-
ception of attenuation of supine SBP (P = 0.08) after further 
adjustment for physical activity.   Use of waist circumference 
or BMI in place of percent body fat as a measure of adipos-
ity yielded similar results, and results were also similar if 
AIx was used in place of AIx75 (data not shown).  The rela-
tionship of 25(OH)D with AIx75 was independent of supine 
and central aortic SBP (data not shown). In MLR models for 
PWV and FMD, 25(OH)D did not meet the a priori criteria 
for model entry with ethnic group in the models (P = 0.35 
and 0.70, respectively), suggesting the relationship between 
25(OH)D and these variables was not independent of ethnic 
group in analyses among the whole group. 
Analyses by ethnic group
The relationships of 25(OH)D with AIX75 (partial r = −0.44, 
P = 0.05), FMD (partial r = 0.42, P = 0.07), and PWV (par-
tial r = −0.42, P = 0.08) approached significance among AA, 
but not EA (P = 0.44 to 0.96) (all adjusted for age, sex, and 
percent body fat). The relationships of 25(OH)D with AIx75 
and PWV were independent of supine and central aortic SBP 
(data  not  shown).  Ethnic  differences  in  the  relationships 
were not seen with the seated, supine, or central aortic BP.  
Contribution of 25(OH)D to ethnic differences in vascu-
lar measures
Ethnic differences in AIx75, PWV, and FMD were attenu-
ated  after  adjustment  for  age  and  percent  body  fat,  and 
they were further attenuated after additional adjustment for 
25(OH)D (Fig. 2). There was a 93% difference between the 
ethnic groups in AIx75 after adjusting for age and percent 
Figure 1. Relationship of 25(OH)D with AIx75, supine SBP, and aortic blood pressures, adjusted for age, sex, and percent body fat. Filled 
circles indicate AA, open circles indicate EA.
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fat (P = 0.04); further adjustment for 25(OH)D reduced the 
ethnic difference to 45.1% (P = 0.44). For FMD, there was 
a 20.3% difference between the ethnic groups after adjust-
ing for age and percent fat (P = 0.07) which was reduced to 
a 13.8 % difference after additional adjustment for 25(OH)
D (P = 0.53). The ethnic difference in PWV was 6.8% (P 
= 0.02) after adjustment for age and percent fat, and it was 
reduced to a 2.9% ethnic difference after further adjustment 
for 25(OH)D (P = 0.20).
Discussion
  
In this study, we investigated the relationship between circu-
lating 25(OH)D and a comprehensive assessment of vascu-
lar function in apparently healthy AA and EA adults. Results 
indicated that 1) 25(OH)D was associated with several non-
traditional indices of vascular function but not with tradition-
ally-measured BP; however, the strength of the relationships 
with some indices were stronger in AA than in EA; and 2) 
there were ethnic differences in several vascular function 
indices;  however, adjustment for  25(OH)D reduced these 
ethnic differences.  Taken together, these results indicate a 
relevant role for vitamin D in vascular health, particularly 
among AA, a group with a disproportionate risk for CVD.
In our study, 25(OH)D was inversely and independent-
ly associated with central aortic BP, but it was not signifi-
cantly  associated  with  the  traditionally-measured  brachial 
BP. Many studies have examined the relationship between 
25(OH)D and BP using the latter measurement; the results 
have been conflicting [15, 22, 23]. To our knowledge, we are 
the first to investigate the relationship between 25(OH)D and 
central aortic blood pressure. Our findings suggest brachial 
BP, at least in a young adult population, underestimates the 
true relationship between 25(OH)D and BP. NHANES III 
analyses have suggested that linear relationships of 25(OH)
D with SBP are stronger in elderly (ages 65 yr and older) 
compared to younger populations (< 50 yr)[23].  Thus, it 
is possible that with increasing age, relationships between 
25(OH)D and brachial BP become more apparent.
Circulating 25(OH)D was inversely associated with AIx, 
independent of ethnicity and body composition, in our par-
ticipants. AIx is an assessment of arterial wave reflection, 
which is influenced by both peripheral small artery structure/
tone and PWV [24]. Our data thus support a role of vitamin 
D in arterial pressure wave reflection and concur with find-
ings in patients with kidney disease [25], as well as recent 
findings in a separate cohort of healthy adults [6]. Future 
studies should investigate whether vitamin D intervention 
reduces AIx.  
We found, in agreement with others [11, 12], that AIx 
and PWV were higher and FMD was significantly lower in 
AA compared to EA, independent of differences in body 
composition.  Additionally, 25(OH)D is lower in AA [13]. 
Rezai et al [7] report that 25(OH)D accounts for ethnic dif-
ferences in PWV among South Asians compared to African 
Caribbeans and Europeans.  We show that among AA and 
EA, adjustment for differences in 25(OH)D reduces the eth-
nic differences in AIx, PWV, and FMD, suggesting lower 
25(OH)D  among AA  at  least  partially  accounts  for  their 
poorer vascular function compared to EA. This was particu-
larly evident for AIx. Similarly, others have suggested that 
lower 25(OH)D in AA mediated ethnic differences in BP [14, 
15]. Collectively, these data support previous findings that 
25(OH)D may contribute to greater prevalence of peripheral 
vascular disease and cardiovascular morbidity and mortality 
in AA [16, 17].  
We analyzed the relationships of 25(OH)D with vascular 
measures within each ethnic group because of the potential 
confounding of low 25(OH)D and poorer vascular function 
reduced arterial compliance among AA compared to EA. Re-
sults suggested that 25(OH)D was associated with AIx, PWV, 
Figure 2. Ethnic differences in vascular function a) unad-
justed, b) adjusted for age and percent body fat, and c) 
further adjusted for 25(OH)D.
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and FMD in AA, but not in EA. The sample sizes precluded 
sufficient  power  to  obtain  statistically  significant  results; 
thus these findings can only be considered hypothesis-gener-
ating. It is possible that the disparate relationships between 
25(OH)D and vascular function may be a result of differ-
ing phenotypes at the cellular/molecular level of endothelial 
cells [26]. As AA have superior bone quality and calcium 
economy compared to EA [27], it is also conceivable that 
vitamin D acts preferentially at bone in EA and at non-skel-
etal tissues in AA. Vitamin D supplementation significantly 
reduced PWV in AA adolescents [5] and increased FMD 
[4] in AA adults, however vitamin D supplementation trials 
aimed at PWV or FMD have not been performed in healthy, 
EA populations. Thus, future randomized and controlled tri-
als including sufficient sample sizes of both EA and AA are 
warranted. The current study also underscores the difficulties 
of assessing cross-sectional relationships of 25(OH)D with 
health outcomes in mixed ethnic group cohorts where there 
are differences in both 25(OH)D and health outcomes.  
There are many potential mechanisms mediating a vi-
tamin D effect on vascular function.  Vascular smooth mus-
cle and endothelial cells express vitamin D receptors and 
1α-hydoxylase [3, 28], allowing for autocrine production of 
1, 25-dihydroxyvitamin D (the biologically active form of 
vitamin D), which has been shown to regulate various cel-
lular processes, including cell proliferation [29]. Other po-
tential mechanisms linking vitamin D to vascular health are 
decreases in oxidative stress [2], attenuation of NF-κB acti-
vation and subsequent inflammation [3], reduction of para-
thyroid hormone [30], and/or down regulation of the renin-
angiotensin-aldosterone system [22]. 
A strength of the study is the investigation of 25(OH)
D relationships with a comprehensive assessment of vascu-
lar function. Furthermore we used a robust measure of body 
composition to account for potential confounding effects of 
adiposity. The cross-sectional design precludes cause-and-
effect inferences. It is yet to be established if alteration of 
these relatively novel measures of vascular function reduces 
CVD risk. We did not assess mechanistic pathways through 
which 25(OH)D could be cardio-protective, such as the re-
nin-angiotensin system or parathyroid hormone. The small 
sample  size  limited  the  number  of  potential  confounders 
that could be included in analyses and our ability to obtain 
statistically significant results in some sub-group analyses. 
Finally, it is possible that these findings may not be gener-
alizable to other ethnic or age groups or groups of different 
health status.  
Conclusion
Circulating 25(OH)D was associated with various relatively 
novel indicators of vascular function, including arterial stiff-
ness and endothelial function. Efforts to improve vitamin D 
status may be particularly relevant in AA, as the relation-
ships appeared to be stronger in this ethnic group compared 
to EA. Long-term, randomized, placebo-controlled trials in-
vestigating vitamin D supplementation effects on vascular 
function among multiple ethnic groups are warranted.
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